Latest News

 Filter by Provider

Tighter memory supply in 2027 can send Micron stock higher.

Slowing new supply in build-to-rent communities gives existing operators room to maintain occupancy and pricing power.

(BPT) - November is National Epilepsy Awareness Month, an opportunity to increase understanding of a neurological condition that affects one in 26 people in the U.S. But understanding epilepsy means also recognizing that there is no single epilepsy experience.

Consumer products company Colgate-Palmolive (NYSE:CL) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 4.6% year on year...

Tesla stemmed the Magnificent Seven's losses this week, as tech stocks struggled due to fears about overspending on AI.

Anthropic is spending big with several cloud providers.

Regeneron stock popped Thursday after its Sanofi-partnered allergic conditions drug, Dupixent, easily beat sales calls.

Why did most of the gap show up only after 2018?

AbbVie stock slipped slightly Friday, but the drug giant easily beat third-quarter forecasts with help from its biggest drug.

A softer backlog outlook overshadowed ServiceNow’s AI momentum. Here’s what investors should know.

Was the neocloud sell-off a valid warning about the economics of AI infrastructure, or has it created a buying opportunity?

Coinbase trades at 55x forward earnings while Morningstar sits at 18x, but one faces crypto volatility and the other battles data-provider competition.

ServiceNow stock fell about 20% after a Q3 earnings miss, but 20.5% revenue growth, rising AI contract value, strong cash flow, and bullish analyst and institutional support suggest a potential recovery.

Consumer finance company OneMain Holdings (NYSE:OMF) announced better-than-expected revenue in Q3 2026, with revenue up 7.3% year on year to $1.36 billion. I...

A promising AI data-center opportunity is approaching a critical financial test. Discover what Navitas has achieved, what remains uncertain, and which numbers could change the investment case.

Biotech company Regeneron (NASDAQ:REGN) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue up 36.3% year on year to $5.12 billion....

Celestica's terrific growth potential and cheap valuation suggest that it can easily become a multibagger.

Integrated energy company Chevron (NYSE:CVX) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue rising 36.3% year on year to $67.8...

Could Elon Musk use "physical AI" to forge a wireless network deal?

Children’s apparel manufacturer Carter’s (NYSE:CRI) met Wall Street’s revenue expectations in Q3 2026, but revenue was flat year on year at $752.5 million. O...

Brookfield’s multiple growth engines could double its stock price over the next five years.

Fee cuts and slower lending growth signal a strategic shift toward deposit stability over loan volume.

Gold faces a series of headwinds, but its long-term trajectory is crystal clear.

Kits Eyecare (TSE:KITS) said it has surpassed a C$250 million annualized revenue run rate after reporting preliminary quarterly revenue of about C$63.7 million, as growth in its higher-margin eyeglasses business accelerated. Speaking at Planet MicroCap Toronto 2026, Olivia Evans, KITS’ director of

Huntington Ingalls Industries (NYSE:HII) reported record third-quarter 2026 revenue of approximately $3.5 billion, up 10.8% from a year earlier, as growth at its Newport News and Ingalls shipyards drove higher shipbuilding sales. Diluted earnings per share rose to $5.48 from $3.68 in the prior-year